secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inari Medical, Inc. (—)
CIK:        0001531048
Form:       8-K
Filed at:   2023-11-15T23:59:59+00:00
Accession:  0001531048-23-000034
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inari Medical closes $250M acquisition of LimFlow for CLTI limb salvage
-----------------------------------------------------------------------

- Paid ~$238.4M at closing after adjustments; total upfront $250M cash from existing resources.
- Up to $165M in contingent milestones payable between 2025-2027 based on commercial/reimbursement goals.
- LimFlow is a pioneer in limb salvage for chronic limb-threatening ischemia (CLTI).
- Financial statements and pro forma results to be filed within 71 days of this report.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1531048/000153104823000034/0001531048-23-000034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1531048/000153104823000034/nari-20231115.htm
  HTML page:      https://secwatch.observer/filing/0001531048-23-000034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer